Home / People / Tjeerd Hoekstra
Portrait ofTjeerd Hoekstra

Tjeerd Hoekstra

Advocaat

CMS Derks Star Busmann
Atrium - Parnassusweg 737
1077 DG Amsterdam
PO Box 94700
1090 GS Amsterdam
Netherlands
Languages German, English, Dutch

Tjeerd Hoekstra is an advocaat in our Employment & Pensions Practice Area Group. He specialises in individual and collective labour law, with a focus on employee representation, reorganisations and the dismissal of directors appointed under the articles of association.​

Among other things, Tjeerd advises large and mid-size companies on employment law issues linked to mergers and acquisitions, such as employee co-determination rights and employment conditions.​

Furthermore, Tjeerd litigates frequently in dismissal cases or other employment-related disputes. Tjeerd is member of the CMS Life Sciences Group and regularly advises companies from that sector on employment-related matters.​

Prior to joining CMS in 2011, Tjeerd practised law in the labour law and procedural law divisions of Clifford Chance LLP based in Amsterdam

more less

Education

  • Labour Law, Grotius Academy for Post-Graduate Law Studies
  • Dutch Law (Economy-related Public and Company Law), Utrecht University
  • Dutch Law (Private Law), Utrecht University
more less

Feed

09/06/2022
CMS advised Korys Investments on its Series B investment round of € 15...
CMS advised Korys Investments N.V. on its participation in a EUR 15 million Series B investment round regarding Trunkrs B.V.Korys Investments N.V. is the investment firm of the Colruyt family. Korys is...
23/05/2022
CMS assists Financial Lease Nederland with sale of majority stake to Egeria
CMS assisted the founders of Financial Lease Nederland B.V. with the sale of a majority stake in Financial Lease Nederland B.V. to Egeria. Financial Lease was founded in 2011 and is one of the major players...
17/05/2021
CMS advises Turn/River Capital on €315m strategic investment in Redwood...
International law firm CMS has advised growth equity firm Turn/River Capital on its €315 million strategic investment in Redwood Software, a leading provider of cloud-based business and IT process automation...
07/07/2020
CMS advises Immatics on the business combination with Arya Sciences Acquisition...
Immatics N.V. has announced the completion of its business combination with Arya Sciences Acquisition Corporation. The Immatics shares and warrants are now traded under the symbol “IMTX” and the...
13/11/2018
CMS advises HNA Group on sale of TIP Trailer Services to I Squared Capital
CMS advised HNA Group, a global conglomerate focused on aviation, tourism, logistics and financial services, on the high value sale of TIP Trailer Services to I Squared Capital, a New York-headquartered...
20/09/2018
CMS acts on the sale of funeral insurance company Nuvema
CMS has acted for Conservatrix Groep S.à.r.l. on the sale of N.V. Nederlandse Uitvaart Verzekering Maatschappij (Nuvema) to Lifetri Group. Nuvema is a funeral insurance company with approximately 185.000...
06/10/2017
CMS advises on the sale of Nederland Isoleert
CMS has advised the selling shareholders on the sale of Nederland Isoleert to Essent.Nederland Isoleert is a company that focuses on housing insulation for private individuals. With the acquisition by...
25/07/2017
CMS acts for Cott Corporation on sale of bottling business to Refresco
CMS has acted for Cott Corporation on the sale of its bottling activities for non-alcoholic beverages to Refresco Holding N.V. for a purchase price of USD 1.25 billion. The transaction is subject to approval...
29/03/2016
CMS advises Kiefel GmbH on the acquisition of Bosch Sprang
CMS has advised Kiefel GmbH on the acquisition of Bosch Sprang. Kiefel is a world-wide manufacturer of plastic foil machinery. Bosch Sprang, a group with some 100 employees, specialises in the production...
11/11/2015
CMS advises Curetis at its IPO
Curetis N.V., a developer of next-level molecular diagnostic solutions, today completed its initial public offering on Euronext in Amsterdam and Euronext in Brussels. At its IPO, Curetis raised € 40...
24/09/2015
CMS advises EPIRUS Bio­phar­ma­ceut­ic­als, Inc. on the acquisition of Bioceros...
CMS has advised EPIRUS Bio­phar­ma­ceut­ic­als, Inc. on the acquisition of Bioceros Holding B.V. EPIRUS Bio­phar­ma­ceut­ic­als, Inc. is a NASDAQ listed biosimilar company focused on the global development and...
16/03/2015
Netherlands: Third time does the trick
Dutch employers have to have regard to the mandatory provisions of Dutch employment law. In that respect, key decisions have to be taken sometimes on how to deal with those mandatory provisions. Clause...